nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A community-based landmark trial to save the lives of pregnant adolescents and their newborns in sub-Saharan Africa
|
Hodnett, Ellen |
|
|
405 |
10497 |
p. 2258-2259 |
artikel |
2 |
Assisted dying bill advances in the House of Commons
|
Thornton, Jacqui |
|
|
405 |
10497 |
p. 2270 |
artikel |
3 |
Challenges of the current yellow fever outbreak in Colombia
|
Alvarez-Moreno, Carlos A |
|
|
405 |
10497 |
p. 2273 |
artikel |
4 |
Clade IIb mpox outbreak in Sierra Leone
|
Mitjà, Oriol |
|
|
405 |
10497 |
p. 2274-2275 |
artikel |
5 |
Clozapine: old drugs require efforts to improve patient experience and access
|
Fanshawe, Jack B |
|
|
405 |
10497 |
p. 2259-2261 |
artikel |
6 |
Community-based mentoring to reduce maternal and perinatal mortality in adolescent pregnancies in Sierra Leone (2YoungLives): a pilot cluster-randomised controlled trial
|
Fernandez Turienzo, Cristina |
|
|
405 |
10497 |
p. 2302-2312 |
artikel |
7 |
Department of Error
|
|
|
|
405 |
10497 |
p. 2278 |
artikel |
8 |
Early-onset type 2 diabetes: no time for defeatism
|
The Lancet, |
|
|
405 |
10497 |
p. 2255 |
artikel |
9 |
Early-onset type 2 diabetes: the next major diabetes transition
|
Luk, Andrea |
|
|
405 |
10497 |
p. 2313-2326 |
artikel |
10 |
Ending nuclear weapons, before they end us
|
Abbasi, Kamran |
|
|
405 |
10497 |
p. 2262-2264 |
artikel |
11 |
Future of once-weekly insulins in type 2 diabetes: efficacy and safety
|
Chow, Edith Wing-Kar |
|
|
405 |
10497 |
p. 2256-2258 |
artikel |
12 |
Genocide in Gaza: moral and ethical failures of medical institutions
|
Niu, Helena |
|
|
405 |
10497 |
p. 2271-2272 |
artikel |
13 |
Lenacapavir approved for HIV but draws ire over cost
|
Cousins, Sophie |
|
|
405 |
10497 |
p. 2269 |
artikel |
14 |
Leptospirosis deaths in children in the Amazon: syndemic inequities
|
Ortiz-Prado, Esteban |
|
|
405 |
10497 |
p. 2275 |
artikel |
15 |
Managing early-onset type 2 diabetes in the individual and at the population level
|
Misra, Shivani |
|
|
405 |
10497 |
p. 2341-2354 |
artikel |
16 |
Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial
|
Philis-Tsimikas, Athena |
|
|
405 |
10497 |
p. 2279-2289 |
artikel |
17 |
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial
|
Blevins, Thomas |
|
|
405 |
10497 |
p. 2290-2301 |
artikel |
18 |
Open letter in support of WHO
|
Bozicevic, Ivana |
|
|
405 |
10497 |
p. 2272-2273 |
artikel |
19 |
Population health impact of NICE-recommended new drugs
|
Gladwell, Daniel |
|
|
405 |
10497 |
p. 2276-2277 |
artikel |
20 |
Population health impact of NICE-recommended new drugs
|
Mueller, Thomas |
|
|
405 |
10497 |
p. 2275-2276 |
artikel |
21 |
Population health impact of NICE-recommended new drugs
|
Ramagopalan, Sreeram V |
|
|
405 |
10497 |
p. 2277 |
artikel |
22 |
Population health impact of NICE-recommended new drugs
|
Holm, Søren |
|
|
405 |
10497 |
p. 2276 |
artikel |
23 |
Population health impact of NICE-recommended new drugs – Authors' reply
|
Naci, Huseyin |
|
|
405 |
10497 |
p. 2277-2278 |
artikel |
24 |
Reorienting frailty in clinical practice, public health, and policy: the Lancet Commission on Frailty
|
Dent, Elsa |
|
|
405 |
10497 |
p. 2265-2266 |
artikel |
25 |
Understanding the drivers and consequences of early-onset type 2 diabetes
|
Lim, Lee-Ling |
|
|
405 |
10497 |
p. 2327-2340 |
artikel |
26 |
US Supreme Court upholds Tennessee law denying adolescents gender-affirming care
|
Jaffe, Susan |
|
|
405 |
10497 |
p. 2267-2268 |
artikel |